In 2011, the Bohn lab pointed out antinociception versus each chemically induced and inflammation-derived pain, and experiments indicated lack of opioid receptor modulation, but have been not able to define a particular target. "The invention of ACKR3 as a target of conolidine additional emphasises the role of this recently https://holdenfyavk.review-blogger.com/53866214/not-known-details-about-conolidine